Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area gpcr g protein leukotriene receptor'

Search results for: 'research area gpcr g protein leukotriene receptor'

Items 1-10 of 52

Page
per page
  1. ALW-II-41-27
    A3165 ALW-II-41-27
     1 Citation
    Target: Eph Receptors
    Summary: Eph receptor inhibitor
      ≥60.8 mg/mL
  2. Imatinib (STI571)
    B2171 Imatinib (STI571)
    Target: PDGFR|c-Kit|Bcr-Abl
    Summary: Protein-tyrosine kinase inhibitor
      ≥24.68 mg/mL
  3. ML347
    B3688 ML347
    Target: BMP and Other Activin Receptors
    Summary: BMP receptor inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥5.87 mg/mL
  4. LDN-193189
    A8324 LDN-193189
    Target: BMP and Other Activin Receptors
    Summary: ALK inhibitor,potent and selective
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O
  5. DMH-1
    B3686 DMH-1
    Target: BMP and Other Activin Receptors
    Summary: Selective BMP ALK2 receptor
      insoluble in H2O; insoluble in EtOH; ≥9.51 mg/mL
  6. SB525334
    A5602 SB525334
    Summary: (TGF-beta1) receptor inhibitor
      ≥34.3 mg/mL
  7. ANA 12
    B5712 ANA 12
     1 Citation
    Target: Trk Receptors
    Summary: TrkB receptor antagonist
      insoluble in H2O; insoluble in EtOH; ≥10.175 mg/mL
  8. Vatalanib (PTK787) 2HCl
    A1778 Vatalanib (PTK787) 2HCl
    Target: VEGFR
    Summary: Tyrosine kinase receptor inhibitor
      ≥21 mg/mL
  9. ZM323881
    A3954 ZM323881
    Target: VEGFR
    Summary: VEGFR-2/KDR inhibitor,potent and selective
      Soluble in DMSO
  10. Tyrphostin AG 1296
    A2477 Tyrphostin AG 1296
     1 Citation
    Target: PDGFR
    Summary: PDGFR inhibitor,selective and ATP-competitive

Items 1-10 of 52

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Axl 2item
  2. ALK 4item
  3. Broad Spectrum Protein Kinase Inhibitor 1 item
  4. c-FMS 1 item
  5. c-Kit 2item
  6. c-MET 4item
  7. c-RET 2item
  8. CSF-1R 1 item
  9. EGFR 7item
  10. EphB4 1 item
  11. FAK 4item
  12. FGFR 3item
  13. FLT3 2item
  14. HER2 3item
  15. IGF1R 3item
  16. IRAK 2item
  17. PDGFR 7item
  18. Pyk2 2item
  19. Spleen Tyrosine Kinase (Syk) 1 item
  20. Src 2item
  21. Tie-2 1 item
  22. Trk 3item
  23. VEGFR 11item
Reversibility
  1. Reversible 5item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Raf 2item
  3. CSF-1R 1 item
  4. FLT3 2item
  5. Eph Receptors 1 item
  6. VEGFR 13item
  7. PDGFR 9item
  8. c-Kit 6item
  9. RET 1 item
  10. IRAK 2item
  11. Bcr-Abl 2item
  12. FGFR 4item
  13. Insulin-like growth factor receptors(IGFRs) 1 item
  14. MET 2item
  15. Src 1 item
  16. Trk Receptors 2item
  17. EGFR 5item
  18. FAK 4item
  19. BMP and Other Activin Receptors 3item
  20. Syk 1 item
  21. ErbB 2item
  22. c-MET 2item
  23. PKC 1 item
  24. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  25. Lyn 1 item
  26. HER2 1 item
  27. Pyk2 3item
  28. S1P receptors 1 item
  29. Insulin and Insulin-like Receptors 2item
  30. PKG 1 item
  31. PKA 1 item
  32. Myosin light chain kinases (MLCKs) 1 item
  33. c-Fyn 1 item
  34. AXL 1 item
  35. c-Fms tyrosine kinase 1 item
  36. tropomyosin receptor kinase 1 item
Reported Experiments
  1. Animal Experiments 45item
  2. Cell Experiments 23item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Adrenocortical Carcinoma 1 item
  3. Autoimmune Diseases 1 item
  4. Bladder Cancer 3item
  5. Breast Cancer 11item
  6. Cancer 39item
  7. Cervical Cancer 1 item
  8. Clear Cell Renal Cell Carcinoma 1 item
  9. Colon Cancer 1 item
  10. Colon Carcinoma 1 item
  11. Colorectal Cancer 9item
  12. Glioblastoma 4item
  13. Glioma 1 item
  14. Hepatocellular Carcinoma 2item
  15. Liver Cancer 2item
  16. Lung Cancer 5item
  17. Lung Carcinoma 1 item
  18. Lymphoma 1 item
  19. Melanoma 2item
  20. Multiple Myeloma 4item
  21. Myeloma 1 item
  22. Non-small Cell Lung Cancer 4item
  23. Ovarian Cancer 5item
  24. Pancreatic Cancer 6item
  25. Prostate Cancer 4item
  26. Pulmonary Arterial Hypertension 1 item
  27. Renal Cell Carcinoma 2item
  28. Thyroid Cancer 1 item